RIME

#4959
Algorhythm Holdings, Inc. - Common Stock
0.2 6 USD
-0.07%
Market Price
Sektor: Technologie
Basis: USD
Gewinnwährung: USD
Tagesspanne
0.26
0.26
Jahresspanne
0.22
4.58
Tagesänderung
-7.14%
Monatliche Änderung
-36.59%
6 month change
-84.05%
Jahresänderung
-87.85%
Vorheriger Schlusskurs
0.2 8
Open
0.2 6
Tief
0.2 6
Hoch
0.2 6
Volumen
4
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Documents

2026

Current report, Q3 FY2026
Algorhythm Holdings, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Algorhythm Holdings, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Algorhythm Holdings, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Algorhythm Holdings, Inc. quarterly report, Q1 FY2026
10-Q

Algorhythm Holdings, Inc. current report, Q4 FY2025

Full document

Business Context and Reporting Period

Company: Algorhythm Holdings, Inc. (Ticker: RIME)
Filing Type: Form 8-K (Current Report)
Date of Report: November 28, 2025
Reporting Period: The filing addresses a deficiency identified in the Quarterly Report on Form 10-Q for the period ended September 30, 2025.

Key Financial Metrics

The filing does not provide revenue, profit, cash flow, or margin data. The only specific financial metric disclosed is:

  • Stockholders' Equity (as of Sept 30, 2025): $100,000
  • Nasdaq Minimum Requirement: $2,500,000

Material Changes and Listing Status

On November 28, 2025, the Company received a notice from the Nasdaq Stock Market Staff indicating a failure to satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1) due to insufficient stockholders' equity. The reported equity of $100,000 is significantly below the required $2,500,000 minimum. The notice states there is no immediate impact on the listing of the Company's common stock.

Outlook, Management Commentary, and Risks

Compliance Plan: The Company has 45 calendar days (until January 12, 2026) to submit a plan to regain compliance. Management intends to submit this plan timely.
Extension Possibility: If the plan is accepted, the Staff may grant an extension of up to 180 calendar days to achieve compliance.
Risks and Contingencies:

  • There is no assurance the Staff will accept the compliance plan.
  • There is no assurance the Company will regain compliance within any granted extension period.
  • If the plan is rejected, the Company may appeal to a hearings panel, which would stay any delisting action.

Investor Verification Checklist

  • Verify the Company's submission of a compliance plan to Nasdaq by January 12, 2026.
  • Monitor the Nasdaq Staff's decision on the acceptance of the compliance plan.
  • Review the Form 10-Q for the period ended September 30, 2025, for full financial context regarding the $100,000 equity balance.
  • Watch for any subsequent 8-K filings regarding the outcome of the compliance plan or potential delisting proceedings.